To subscribe:
To have your comment included in a future podcast, call 617-440-4374. Please leave your name, number, and the podcast ID number.
(2 votes, average: 3.00 out of 5)
(3 votes, average: 2.33 out of 5)
(1 votes, average: 5.00 out of 5)You’d think that a widely-ordered test would play a part in management and outcome, but two clotting mutations seem exceptions to that rule. Although often requested, the FDA-approved tests for Factor V Leiden and G20210A mutations don’t seem to figure greatly in case management of venous thromboembolism, at least according to the published literature. Dr. [...]
(1 votes, average: 1.00 out of 5)We talk about writing with Danielle Ofri, editor of the Bellevue Literary Review, author of “Singular Intimacies: Becoming a Doctor at Bellevue” and “Incidental Findings: Lessons from My Patients in the Art of Medicine,” and an attending physician at Bellevue. I figured you could do with less information about influenza. If you’ve got a reaction, [...]
(1 votes, average: 3.00 out of 5)NEJM published a paper this week detailing the risks of sudden cardiac death in those taking both typical and atypical antipsychotic drugs. We talk with the paper’s first author Dr. Wayne A. Ray of Vanderbilt University School of Medicine. If you would like to comment or offer an idea for a future podcast, please call [...]
(1 votes, average: 1.00 out of 5)The medical news gods were generous this week, providing a wealth of stories to choose from. Plus, the Nobel prizes were announced. We’re especially fortunate to have an interview with a researcher whose findings relate directly to your clinical work. Journal Watch links: Patients and Caregivers Benefit from End-of-Life Discussions Tiotropium Alleviates Symptoms, Doesn’t Reduce [...]
